RB1

There are 223 papers on RB1 in aging research: 3 trials and 21 observational studies in people, 74 in animals, 95 in cells, 26 reviews. The newest story, Nov 5, 2026: “Rare gene variants linked to benign fat and uterine tumors”.

Gene

223 papers study it30 findings

HGNCNCBI GeneTaxon

4 new papers in 30 daysSee all 223 papers on RB1

At a glance

The findings reach people, from one lab or study; independent labs found the same change in cells. 15 independent labs in 10 countries.

“aggregated rare pathogenic variants in these 8 genes were significantly associated with lung cancer risk and earlier age at lung cancer diagnosis, independent of and complementary to smoking history at recruitment.”
Association Between Rare Germline Variants in Cancer Susceptibility Genes and Lung Cancer RiskThe Annals of thoracic surgery2026doi:10.1016/j.athoracsur.2026.07.025

1 of its findings points the other way.

Cells: replicated by independent labs. Mice and humans: a single group. Worms or flies: nothing yet.
  • 15 independent labs in 10 countries
  • 1 finding against
  • Funders: National Cancer Institute and others
  • 4 of 23 findings with company ties
  • Human trial3
  • Humans21
  • Animals73
  • Model organisms1
  • Cells95
  • In silico4

Interventions

1

Vitamin D

upin humans1

1 study
  1. Vitamin D increases RB1 in humans (prediabetic individuals).

    “along with a significant elevation of retinoblastoma protein levels in the circulatory system.”

    Human trialprediabetic individuals

    Effect of Vitamin D on Retinoblastoma Protein in Prediabetic Individuals

    Current diabetes reviews

More on Vitamin D

Effects

15

Cellular senescence

is required forin human cells3upin cells2upin human cells1downin mouse cells1+1

8 studies
  1. RB1 induces cellular senescence in human cells (RB1 knockdown).

    “Knocking down RB1 promoted proliferation and suppressed senescence”

    CellsRB1 knockdown

    A machine learning-driven framework integrating cell death and senescence signatures for multi-target drug design and immunotherapy optimization in ovarian cancer

    NPJ precision oncology

  2. RB1 mediates cellular senescence.

    “RB is crucial in mediating senescence and tumor suppression by modulating the RB-E2F pathway”

    Review

    RB functions as a key regulator of senescence and tumor suppression

    Seminars in cancer biology

  3. RB1 is required for cellular senescence in human cells (senescence induced by repression-deficient FOXM1 mutants, shown by RB1 depletion).

    “repression-deficient mutants of FOXM1 induce senescence that is blocked by depletion of RB1 or FOXO1.”

    Cellssenescence induced by repression-deficient FOXM1 mutants, shown by RB1 depletionhepatocellular carcinoma cell

    Hepatocellular carcinoma evades RB1-induced senescence by activating the FOXM1-FOXO1 axis

    Oncogene

  4. RB1 is required for cellular senescence in human cells (depletion in RABL6A-silenced NHSCs).

    “premature stress-induced senescence, which was largely rescued by co-depletion of RB1”

    Cellsdepletion in RABL6A-silenced NHSCsSchwann cell

    RABL6A Regulates Schwann Cell Senescence in an RB1-Dependent Manner

    International journal of molecular sciences

  5. RB1 increases cellular senescence in cells (shown by siRNA knockdown).

    “SiRNA-mediated knockdown of RB led to suppression of cell senescence and the SASP.”

    Cellsshown by siRNA knockdowncorneal endothelial cells

    Retinoblastoma ( Rb ) promotes senescence of corneal endothelial cells by inhibiting the activation of E2F2

    Preprint

  6. RB1 is required for cellular senescence in human cells (senescence response to altered ribosome biogenesis).

    “Rb but not p53 was required for the senescence response to altered ribosome biogenesis”

    Cellssenescence response to altered ribosome biogenesis

    Senescence-associated ribosome biogenesis defects contributes to cell cycle arrest through the Rb pathway

    Nature cell biology

  7. RB1 induces cellular senescence in cells (RB activation independently of direct DNA damage).

    “activating RB independently of direct DNA damage also results in repression of DNA repair genes and in the subsequent induction of DNA damage and senescence.”

    CellsRB activation independently of direct DNA damage

    Transcriptional repression of DNA repair genes is a hallmark and a cause of cellular senescence

    Cell death & disease

  8. RB1 decreases cellular senescence in mouse cells (silencing RB1).

    “silencing RB1 in mouse fibroblasts induced a reduced senescence not observed in mouse MSCs.”

    Cellssilencing RB1

    Misidentified Human Gene Functions with Mouse Models: The Case of the Retinoblastoma Gene Family in Senescence

    Neoplasia (New York, N.Y.)

More on Cellular senescence

Cardiomyocyte reprogramming

downin human cells1downin mouse cells1

1 study
  1. RB1 inhibits cardiomyocyte reprogramming in human cells during direct cardiac reprogramming.

    “Knockdown of these genes, particularly RB1, significantly enhanced reprogramming efficiency, increasing the proportion of GFP + cells in MEFs and α-actinin + cells in hFCFs.”

    Cellsduring direct cardiac reprogramming

    Enhancing cardiomyocyte reprogramming efficiency by targeting cellular senescence is mediated via Rb1 gene

    Stem cell research & therapy

  2. RB1 inhibits cardiomyocyte reprogramming in mouse cells during direct cardiac reprogramming.

    “Knockdown of these genes, particularly RB1, significantly enhanced reprogramming efficiency, increasing the proportion of GFP + cells in MEFs and α-actinin + cells in hFCFs.”

    Cellsduring direct cardiac reprogramming

    Enhancing cardiomyocyte reprogramming efficiency by targeting cellular senescence is mediated via Rb1 gene

    Stem cell research & therapy

Tumor growth

downin mice1

1 study
  1. RB1 inhibits tumor growth in vivo RB1 overexpression.

    “In vivo, RB1-overexpressing tumors showed restrained growth and elevated immune infiltration.”

    Animalsin vivo RB1 overexpression

    A machine learning-driven framework integrating cell death and senescence signatures for multi-target drug design and immunotherapy optimization in ovarian cancer

    NPJ precision oncology

Nuclear architecture changes

upin humans1

1 study
  1. RB1 induces nuclear architecture changes in humans (active forms of RB).

    “active forms of RB cause widespread changes in nuclear architecture that are visible under a microscope”

    Reviewactive forms of RB

    Seeing is believing: the impact of RB on nuclear organization

    Cell cycle (Georgetown, Tex.)

DNA damage response

downin mice1

1 study
  1. RB1 prevents DNA damage response in mice (Rb deficiency).

    “In the absence of Rb, we also show evidence of incomplete cell cycle re-entry (CCE) along with DNA damage in the young OB”

    AnimalsRb deficiencyolfactory bulb

    Aging entails distinct requirements for Rb at maintaining adult neurogenesis

    Aging brain

More on DNA damage response

Progenitor proliferation

no changein mice1

1 study
  1. RB1 showed no clear effect on progenitor proliferation in mice (Rb iKO).

    “we find no evidence of irregular proliferation or early commitment defects in the mid-aged (12-month-old) and old-aged (20-month-old) SVZ following tamoxifen-inducible Rb knockout (Rb iKO) in mice”

    AnimalsRb iKOsubventricular zone

    Aging entails distinct requirements for Rb at maintaining adult neurogenesis

    Aging brain

HTC

downin reviews1

1 study
  1. RB1 inhibits HTC in oncogene-expressing cells.

    “The HTC is repressed by the tumor suppressors p53 and RB”

    Reviewin oncogene-expressing cells

    A novel redox cycle diverts cells from oncogene-induced senescence into cancer

    Molecular cell

Cell function and migratory ability

no changein cells1

1 study
  1. RB1 showed no clear effect on cell function and migratory ability in cells after RB intervention.

    “did not influence the cell function or migratory ability.”

    Cellsafter RB interventioncorneal endothelial cells

    Retinoblastoma ( Rb ) promotes senescence of corneal endothelial cells by inhibiting the activation of E2F2

    Preprint

E2F2

downin cells1

1 study
  1. RB1 inhibits E2F2 in cells (shown by siRNA knockdown).

    “Knockdown of RB promoted the activation of E2F2.”

    Cellsshown by siRNA knockdowncorneal endothelial cells

    Retinoblastoma ( Rb ) promotes senescence of corneal endothelial cells by inhibiting the activation of E2F2

    Preprint

More on E2F2

Proliferation pause

mediatesin human cells1

1 study
  1. RB1 mediates proliferation pause in human cells (OSK-induced reprogramming; absent in immortalized fibroblasts).

    “The RB-regulated proliferation pause does not occur in immortalized fibroblasts”

    CellsOSK-induced reprogramming; absent in immortalized fibroblastsfibroblast

    MYC Releases Early Reprogrammed Human Cells from Proliferation Pause via Retinoblastoma Protein Inhibition

    Cell reports

All 15

Upstream

1

CDKN1A

upin cells1

1 study
  1. CDKN1A activates RB1 in G2 phase in non-transformed cells.

    “In non-transformed cells, p21 activates RB in G2 by inhibiting Cyclin D1-CDK2/CDK4.”

    Cellsin G2 phase in non-transformed cells

    Reciprocal regulation of p21 and Chk1 controls the Cyclin D1-RB pathway to mediate senescence onset after DNA damage-induced G2 arrest

    bioRxiv (Cold Spring Harbor Laboratory)Preprint

More on CDKN1A

Associations

4

Cellular senescence

upin humans1mixedin reviews1

2 studies
  1. RB1 is associated with cellular senescence in humans (active forms of RB).

    “or in IMR-90 cells with senescence markers”

    Reviewactive forms of RBIMR-90

    Seeing is believing: the impact of RB on nuclear organization

    Cell cycle (Georgetown, Tex.)

  2. Cellular senescence is associated with RB1 in senescent cells.

    “phosphorylation of the retinoblastoma gene is altered in senescent cells”

    Reviewin senescent cells

    Genetic and molecular basis for cellular senescence

    Advances in experimental medicine and biology

More on Cellular senescence

Lung cancer

upin humans1

1 study
  1. RB1 is associated with lung cancer in humans.

    “aggregated rare pathogenic variants in these 8 genes were significantly associated with lung cancer risk and earlier age at lung cancer diagnosis, independent of and complementary to smoking history at recruitment.”

    Humansaggregated rare pathogenic variants in 8 genes (ATM, BRCA2, TP53, RB1, MET, CYLD, PDGFRA, CTNNA1)

    Association Between Rare Germline Variants in Cancer Susceptibility Genes and Lung Cancer Risk

    The Annals of thoracic surgery

More on Lung cancer

Autophagy

upin humans1

1 study
  1. RB1 is associated with autophagy in humans (active forms of RB).

    “were associated with the appearance of autophagy”

    Reviewactive forms of RB

    Seeing is believing: the impact of RB on nuclear organization

    Cell cycle (Georgetown, Tex.)

More on Autophagy

Id family proteins

upin reviews1

1 study
  1. Id family proteins are associated with RB1.

    “Id binds to important cell cycle regulatory proteins other than bHLH proteins”

    Review

    Id proteins in cell cycle control and cellular senescence

    Oncogene

Latest

Dec 2025: 1Jan 2026: 4Feb 2026: 3Mar 2026: 1Apr 2026: 3May 2026: 0Jun 2026: 3Jul 2026: 4Aug 2026: 2Sep 2026: 3Oct 2026: 4Nov 2026: 331 papers in 12 months
medRxiv

Rare gene variants linked to benign fat and uterine tumors

People carrying disabling variants in TERF1, a chromosome-protection gene, had 3.32 times the odds of benign fatty tumors compared with people without those variants.People carrying disabling variants in TERF1, a chromosome-protection gene, had 3.32 times the odds of benign fatty tumors compared with people without those variants.

Preprint: genetic association · 459,449 peoplePopulations
Genome Medicine

Common mutations less favored as esophageal cancer develops

An evolutionary analysis of 2,171 human samples linked common mutations to expansion of normal cells, but found little advantage during progression to cancer.An evolutionary analysis of 2,171 human samples linked common mutations to expansion of normal cells, but found little advantage during progression to cancer.

Computational studyMechanisms
bioRxiv

Loss of the Y chromosome barely alters tumor gene activity

Analyses of human kidney tumors, mice and cell lines showed that losing the Y chromosome produces few broad changes in gene activity across cancers.Analyses of human kidney tumors, mice and cell lines showed that losing the Y chromosome produces few broad changes in gene activity across cancers.

Preprint: cohort study in peopleMechanisms
Frontiers in Pharmacology

Melissic acid reduces senescence in human stem cells via cAMP signaling

A screen of 800 natural compounds identified a phytochemical that activates autophagy and restores cell-cycle activity in models of cellular exhaustion.A screen of 800 natural compounds identified a phytochemical that activates autophagy and restores cell-cycle activity in models of cellular exhaustion.

Experiments in human cellsInterventions

See all 223 papers on RB1